› 100% normobaric oxygen
› Nonrebreather mask at 10 to 15 L/min
› First-line for all DCS presentations
› 14% achieve complete symptom relief
› 51% achieve partial symptom reduction
› Demand valve oxygen delivery
› Higher fraction of inspired oxygen than NRB
› Preferred when available
› Duration of normobaric oxygen
› Continue until recompression available
› Continue throughout transport
› Contraindications to note
› Nitrous oxide absolutely contraindicated — causes bubble expansion
› Avoid glucose-containing IV fluids — worsens neurological injury
› Avoid hypotonic fluids — promote intracellular edema
Hyperbaric oxygen therapy
› US Navy Treatment Table 6 — standard first-line recompression
› Pressurization to 2.8 atm (18 m equivalent)
› 100% oxygen breathing periods
› Air breaks to prevent oxygen toxicity
› Total session approximately 4 hours 45 minutes
› Indications
› All Type II DCS — neurological, vestibular, pulmonary
› Type I DCS not resolving with normobaric oxygen
› Class I recommendation based on expert consensus
› US Navy Treatment Table 5 — mild DCS
› Pressurization to 2.8 atm
› Shorter duration than Table 6
› Total session approximately 2 hours
› Indications
› Mild Type I DCS with complete resolution at pressure
› Repetitive recompression sessions
› Multiple sessions often required for neurological DCS
› Spinal cord DCS may need 5 to 10 or more sessions
› Response assessed clinically after each session
› Tenoxicam adjunct reduces median sessions from 3 to 2
› NSAID RCT evidence supporting adjunctive use
› Hydration protocol
› Oral rehydration if conscious and tolerating
› Isotonic noncarbonated noncaffeinated noncalcoholic fluid
› Water acceptable if preferred option unavailable
› IV isotonic crystalloid for moderate to severe DCS
› Normal saline 0.9% or lactated Ringer's
› Initial bolus 500 to 1000 mL for dehydration
› Titrate to hemodynamic stability
› Avoid glucose-containing solutions
› Risk of hyperglycemia worsening neurological injury
› Avoid hypotonic solutions
› Promote intracellular edema in neurological injury
› NSAIDs
› Tenoxicam
› Reduced median recompression sessions from 3 to 2 in RCT
› Standard oral NSAID dosing
› Adjunct to recompression — not monotherapy
› Other NSAIDs
› Ibuprofen reasonable alternative
› Avoid in renal impairment or hemorrhagic risk
› DVT prophylaxis for immobile patients
› Fractionated heparin subcutaneous
› Enoxaparin 40 mg SC daily
› For spinal cord DCS with immobility
› Begin after hemorrhagic complications excluded
› IV lidocaine — selected severe neurological AGE
› Neuroprotective in animal models
› Not standard of care — limited human evidence
› Considered by hyperbaric specialists in refractory cases
› Medications without evidence or contraindicated
› Steroids — historically used, lack evidence, not standard
› Aspirin — not formally studied, not recommended routinely
› Nitrous oxide — absolutely contraindicated
› Urinary catheterization
› For urinary retention from spinal cord DCS
› Foley catheter placement
› Monitor urine output
› Positioning
› Supine positioning preferred
› Historical left lateral decubitus no longer recommended
› Trend position does not improve outcomes
› Head of bed neutral for neurological DCS
› Serial neurological examination
› Document deficits before and after each recompression session
› Sensory map documentation
› Motor strength grading
Show 56 more ▾